---
schema_version: "secwatch.filing_event.v1"
accession: "0001757898-24-000005"
form_type: "8-K"
ticker: "STE"
cik: "0001757898"
company_name: "STERIS plc"
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T12:03:43.515848+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# STERIS reports FY2024 revenue up 12% to $5.5B; GAAP EPS $3.81, adjusted EPS $8.83; announces $100M restructuring plan

## Summary
- Q4 revenue $1.5B (+10% YoY); Q4 GAAP net loss $1.4M (-$0.01/sh) vs $187.2M profit in prior year.
- Full-year adjusted EPS grew to $8.83; constant currency organic revenue from cont. ops +10% to $5.0B.
- Restructuring plan: ~$100M total charges, $44.4M recorded in Q4, balance in FY2025; $50M non-cash, $37M employee termination, $13M other.
- Healthcare segment outperformed driven by US strength; CEO cites confidence in long-term growth commitments.

## SEC filing metadata
- accession: 0001757898-24-000005
- form_type: 8-K
- ticker: STE
- cik: 0001757898
- company_name: STERIS plc
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 2.05, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757898/000175789824000005/0001757898-24-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757898/000175789824000005/ste-20240507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001757898-24-000005
- JSON: https://secwatch.observer/filing/0001757898-24-000005.json
- Plain text: https://secwatch.observer/filing/0001757898-24-000005.txt

## Key facts
- Earnings Releases
  STERIS plc reported fiscal 2024 fourth quarter ended March 31, 2024 results: revenue $1.5 billion, net income ($0.01) per diluted share, EPS ($0.01) per diluted share.
  - Period: fiscal 2024 fourth quarter ended March 31, 2024
  - Revenue: $1.5 billion
  - Net income: ($0.01) per diluted share
  - EPS: ($0.01) per diluted share
  - Result: reported results
  source text: Total revenue for the fourth quarter of fiscal 2024 increased 10% to $1.5 billion compared with $1.4 billion in the fourth quarter of fiscal 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1757898/000175789824000005/0001757898-24-000005-index.htm
- Earnings Releases
  STERIS plc reported fiscal 2024 full year ended March 31, 2024 results: revenue $5.5 billion, net income $3.81 per diluted share, EPS $3.81 per diluted share.
  - Period: fiscal 2024 full year ended March 31, 2024
  - Revenue: $5.5 billion
  - Net income: $3.81 per diluted share
  - EPS: $3.81 per diluted share
  - Result: reported results
  source text: Total revenue for fiscal 2024 increased 12% to $5.5 billion compared with $5.0 billion in fiscal 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1757898/000175789824000005/0001757898-24-000005-index.htm
- Restructurings & Charges
  STERIS plc announced a restructuring with charges of approximately $100 million affecting Healthcare surgical business in Europe.
  - Type: restructuring
  - Charge: approximately $100 million
  - Affected area: Healthcare surgical business in Europe
  source text: this plan to potentially impacted employees on May 7, 2024 and the restructuring is expected to be substantially completed by the end of fiscal 2025. The approximately $100 million of anticipated restructuring charges includes approximately $44.4 million recorded in the fiscal 2024 fourth quarter with the balance expected to be recorded in fiscal 2025. Of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1757898/000175789824000005/0001757898-24-000005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.